Teen cancer death rate provoked countries to step forward for effective treatment

A report in the Lancet Oncology gives the analysis of survival rates for cancer teenager patients such as leukaemia were so much lower.

A Europe-wide report warns that so many teens and recently known adults are dying because of some types of cancer.

Cancer Research UK said the time has come to figure out what is not happening right.

After researching, the reasons came out to be delayed in diagnosis, differences in tumours, treatment and unproper clinical trials for that age group.

Five-year survival rates were higher in teenagers and young adults at 82% compared with 79% in children.

The study analysed data from 27 countries on nearly 57,000 childhood cancers and 312,000 cancers in teenagers and young adults.

alarming stage

The five-year survival rates for:

Acute lymphoid leukaemias were 56% in teenagers and young adults & 85.8% in children

Acute myeloid leukaemias 50% in teenagers and young adults & 61% in children

Hodgkin’s lymphoma 93% in teenagers and young adults & 95% in children

Non-Hodgkin’s lymphoma 77% in teenagers and young adults & 83% in children

Astrocytomas (a brain cancer) 46% in teenagers and young adults & 62% in children

Ewing’s sarcoma of bone 49% in teenagers and young adults & 67% in children

Rhabdomyosarcoma (soft tissue tumours) 38% in teenagers and young adults & 67% in children

Osteosarcoma (bone cancer) 62% in teenagers and young adults & 67% in children

Dr Annalisa Trama, from The National Institute of Cancer in Milan, Italy said: “The good news is that the number of children, adolescents and young adults surviving for at least five years after diagnosis has risen steadily over time in Europe. “